Trial Profile
Solian Solution to Treat Schizophrenic Patients During an Acute Episode
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jun 2013
Price :
$35
*
At a glance
- Drugs Amisulpride (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms SOLIACS
- Sponsors Sanofi
- 18 Dec 2005 New trial record.